129 related articles for article (PubMed ID: 11958128)
1. Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC.
Deng L; Zhao XR; Pan KF; Wang Y; Deng XY; Lü YY; Cao Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jan; 34(1):16-20. PubMed ID: 11958128
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
3. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
[TBL] [Abstract][Full Text] [Related]
4. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
5. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
6. Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma.
Catarino RJ; Breda E; Coelho V; Pinto D; Sousa H; Lopes C; Medeiros R
Head Neck; 2006 Jul; 28(7):603-8. PubMed ID: 16691558
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population.
Liu W; Zhu E; Wang R; Wang L; Gao L; Yang X; Liu T
Cancer Epidemiol; 2011 Aug; 35(4):e12-7. PubMed ID: 21185249
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
10. [Cyclin D1 gene G870A polymorphism and susceptibility to nasopharyngeal carcinoma].
Sui J; Gao W; Li XJ; Ma J; Ren YX; Song X; Xiao CJ; Tang WR
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):227-31. PubMed ID: 19558863
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
Forones NM; de Lima JM; de Souza LG; da Silva ID
J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population.
Hou X; Wang S; Zhou Y; Xu Z; Zou Y; Zhu X; Han M; Pang T; Han ZC
Int J Hematol; 2005 Oct; 82(3):206-9. PubMed ID: 16207592
[TBL] [Abstract][Full Text] [Related]
14. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
15. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
McKay JA; Douglas JJ; Ross VG; Curran S; Murray GI; Cassidy J; McLeod HL
Int J Cancer; 2000 Oct; 88(1):77-81. PubMed ID: 10964085
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
18. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.
Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H
Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950
[TBL] [Abstract][Full Text] [Related]
20. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population.
Aytekin T; Aytekin A; Maralcan G; Gokalp MA; Ozen D; Borazan E; Yilmaz L
Asian Pac J Cancer Prev; 2014; 15(17):7181-5. PubMed ID: 25227811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]